Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(33), p. 5549-5549, 2015
DOI: 10.1200/jco.2015.33.15_suppl.5549
Links
Tools
Single agent vanucizumab (RO5520985) for platinum (Pt)-resistant recurrent ovarian cancer (OC): Results from a single arm extension phase of the phase I FIH study.
Journal article published in 2015 by
Ana Oaknin,
Anne Floquet,
Christophe Le Tourneau,
Isabelle Laure Ray-Coquard,
Florence Joly,
Manuel Hidalgo,
Alexandra Leary,
Oliver Krieter,
Angelika Lahr,
Simona Rossomanno 
,
Katharina Lechner,
Tapan Nayak,
Christophe Boetsch,
Grozdana Rasuo,
Anthony Morel
and other authors.
,
Katharina Lechner,
Tapan Nayak,
Christophe Boetsch,
Grozdana Rasuo,
Anthony Morel
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 